MUNICH and COPENHAGEN, Denmark, September 6, 2018 /PRNewswire/ — LEUKOCARE AG and Xellia Pharmaceuticals, have entered into a global strategic partnership, where both companies will collaborate closely to discover innovative and superior formulations to support the development of…

View more at https://www.prnewswire.com:443/news-releases/leukocare-and-xellia-pharmaceuticals-partner-to-discover-innovative-formulations-for-the-development-of-value-added-anti-infective-therapies-895560066.html